Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease
NCT01418794
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
606
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndromes
Interventions
DEVICE:
High dose rapamycin stent
DEVICE:
Low dose rapamycin stent
Sponsor
Shenyang Northern Hospital